Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Aggressive Multiple Sclerosis - whom, when and how.
UNUSUAL CLINICAL CASES THAT MIMIC ACUTE DISSEMINATED ENCEPHALOMYELITIS.
Implications for multiple sclerosis in the era of the Affordable Care Act: a clinical overview.
Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.
Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis.
Towards an endophenotype in multiple sclerosis.
Intravenous immunoglobulin preparation attenuates neurological signs in rat experimental autoimmune neuritis with the suppression of macrophage inflammatory protein -1α expression.
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients.
Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute Attacks.
Metabotropic glutamate receptor 5 modulates calcium oscillation and innate immune response induced by lipopolysaccharide in microglial cell.
Sunlight exposure and multiple sclerosis in a tropical country.
Erratum to: The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.
Rabies encephalomyelitis vs. ADEM: Usefulness of MR imaging in differential diagnosis.
Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
Chronic Acquired Demyelinating Polyneuropathy following Renal Transplantation.
Functional ionotropic glutamate receptors on peripheral axons and myelin.
Evaluation of locomotor function and microscopic structure of the spinal cord in a mouse model of experimental autoimmune encephalomyelitis following treatment with syngeneic mesenchymal stem cells.
Functional connectivity underlying postural motor adaptation in people with multiple sclerosis.
Natalizumab to fingolimod: Questions answered, unanswered, and unasked.
Common gut microbe could help prevent development of multiple sclerosis.
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Disutility of Illness for Caregivers and Families: A Systematic Review of the Literature.
Pages
« first
‹ previous
…
520
521
522
523
524
525
526
527
528
…
next ›
last »